You can:
Name | Somatostatin receptor type 4 |
---|---|
Species | Homo sapiens (Human) |
Gene | SSTR4 |
Synonym | SS4R SS4-R SS-4-R SRIF2B SST4 receptor |
Disease | N/A |
Length | 388 |
Amino acid sequence | MSAPSTLPPGGEEGLGTAWPSAANASSAPAEAEEAVAGPGDARAAGMVAIQCIYALVCLVGLVGNALVIFVILRYAKMKTATNIYLLNLAVADELFMLSVPFVASSAALRHWPFGSVLCRAVLSVDGLNMFTSVFCLTVLSVDRYVAVVHPLRAATYRRPSVAKLINLGVWLASLLVTLPIAIFADTRPARGGQAVACNLQWPHPAWSAVFVVYTFLLGFLLPVLAIGLCYLLIVGKMRAVALRAGWQQRRRSEKKITRLVLMVVVVFVLCWMPFYVVQLLNLFVTSLDATVNHVSLILSYANSCANPILYGFLSDNFRRFFQRVLCLRCCLLEGAGGAEEEPLDYYATALKSKGGAGCMCPPLPCQQEALQPEPGRKRIPLTRTTTF |
UniProt | P31391 |
Protein Data Bank | N/A |
GPCR-HGmod model | P31391 |
3D structure model | This predicted structure model is from GPCR-EXP P31391. |
BioLiP | N/A |
Therapeutic Target Database | N/A |
ChEMBL | CHEMBL1853 |
IUPHAR | 358 |
DrugBank | BE0009273 |
Name | SOMATOSTATIN |
---|---|
Molecular formula | C76H104N18O19S2 |
IUPAC name | (4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-37-[[2-[[(2S)-2-aminopropanoyl]amino]acetyl]amino]-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid |
Molecular weight | 1637.9 |
Hydrogen bond acceptor | 24 |
Hydrogen bond donor | 22 |
XlogP | -3.1 |
Synonyms | CHEMBL1823872 Growth hormone-release inhibiting factor: L-alanylglycyl-L-cysteinyl-L-lysyl-L-asparaginyl-L-phenylalanyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine cyclic (3->14) disulfide NCGC00167137-01 Somatostatin [BAN:INN] Somatostatine [INN-French] [ Show all ] |
Inchi Key | NHXLMOGPVYXJNR-ATOGVRKGSA-N |
Inchi ID | InChI=1S/C76H104N18O19S2/c1-41(79)64(100)82-37-61(99)83-58-39-114-115-40-59(76(112)113)92-72(108)57(38-95)91-75(111)63(43(3)97)94-71(107)54(33-46-23-11-6-12-24-46)90-74(110)62(42(2)96)93-66(102)51(28-16-18-30-78)84-69(105)55(34-47-36-81-49-26-14-13-25-48(47)49)88-68(104)53(32-45-21-9-5-10-22-45)86-67(103)52(31-44-19-7-4-8-20-44)87-70(106)56(35-60(80)98)89-65(101)50(85-73(58)109)27-15-17-29-77/h4-14,19-26,36,41-43,50-59,62-63,81,95-97H,15-18,27-35,37-40,77-79H2,1-3H3,(H2,80,98)(H,82,100)(H,83,99)(H,84,105)(H,85,109)(H,86,103)(H,87,106)(H,88,104)(H,89,101)(H,90,110)(H,91,111)(H,92,108)(H,93,102)(H,94,107)(H,112,113)/t41-,42+,43+,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,62-,63-/m0/s1 |
PubChem CID | 16129706 |
ChEMBL | CHEMBL1823872 |
IUPHAR | N/A |
BindingDB | 81767 |
DrugBank | DB09099 |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
N/A | N/A | DrugBank | |
IC50 | 0.08 nM | PMID9216843 | ChEMBL |
IC50 | 0.08 nM | PMID9216843 | BindingDB |
IC50 | 1.6 nM | PMID24378707, PMID15658865 | ChEMBL |
IC50 | 1.7 nM | PMID21806016 | BindingDB,ChEMBL |
Ki | 0.3 nM | PMID10433861 | BindingDB |
Ki | 0.53 nM | PMID7988476 | BindingDB |
Ki | 0.59 nM | PMID11327607 | ChEMBL |
Ki | 0.59 nM | PMID11327607 | BindingDB |
Ki | 0.63 nM | PMID11520208 | ChEMBL |
Ki | 0.74 nM | PMID24342240 | ChEMBL |
Ki | 1.2 nM | PMID10818260 | BindingDB |
Ki | 1.23 nM | PMID10598788, PMID9650799 | BindingDB |
Ki | 1.259 nM | PMID12773038 | ChEMBL |
Ki | 1.26 nM | PMID9290757 | BindingDB |
Ki | 1.34 nM | PMID10598788 | BindingDB |
Ki | 1.4 nM | PMID9822540 | ChEMBL |
Ki | 1.7 nM | PMID16220980 | ChEMBL |
Ki | 1.76 nM | PMID9600011, PMID9724791, PMID12477342 | BindingDB,ChEMBL |
Ki | >2.0 nM | MedChemComm, (2014) 5:8:1150 | ChEMBL |
Ki | 4.07 nM | PMID10598788, PMID9650799 | BindingDB |
pKD | 8.39 - | PMID11448228 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417